Xsensio
1 known investors
Xsensio develops a wearable "Lab-on-Skin" sensing platform for real-time, continuous monitoring of inflammation and other biomarkers to detect clinical deterioration across ICU, outpatient, and home settings. Its first product targets early detection of organ dysfunction for critical care, oncology, and post-surgical recovery, serving healthcare providers.
Investors · 1
Frequently asked questions
- What does Xsensio do?
- Xsensio develops a wearable "Lab-on-Skin" sensing platform for real-time, continuous monitoring of inflammation and other biomarkers to detect clinical deterioration across ICU, outpatient, and home settings. Its first product targets early detection of organ dysfunction for critical care, oncology, and post-surgical recovery, serving healthcare providers.
- Who are Xsensio's investors?
- Xsensio's investors include Privilège Ventures.